Method Development and Method Validation of Daprodustat - Using Reverse phase High Performance Liquid Chromatography Method
Year: 2025
Type: article
Abstract: Aim: Daprodustat in pharmaceutical dosage forms has been previously analyzed quantitatively using reverse-phase high-performance liquid chromatography (RP-HPLC) approach that was easy to use, quick, accurate, sensitive, and repeatable. Materials and methods: Daprodustat was separated chromatographically using a Waters Alliance e2695 system and a Waters X-Terra RP-18 column (150x4.6mm, 3.5µ). The mobile phase was made up of 50% v/v ACN and HSA pH-2.5/OPA. Photodiode array detector was operated at room temperature is utilized to detect absorption at 235 nanometers while the flowrate was fixed at 1.0 ml/minute. Results: For Daprodustat, it was guaranteed that the theoretical plate count and tailing factor would be at least 2000 and 2, respectively. The percentage of standard deviation for peak regions consistently below 2.0 in all measurements. Conclusion: The proposed approach was validated in compliance with ICH requirements, and it was found to be an easy-to-use, reasonably priced, appropriate, precise, accurate, and reliable tool for Daprodustat quantitative evaluation.
Language: English
Subfield: Analytical Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W6930610357
FWCI:
Cites:
Cited by:
Related to: